The Male Default in Medicine π§ͺ
Decades of clinical research was built almost entirely on male specimens β both human and animal. The premise was that there are "few significant differences" between male and female biology, an assumption we now know to be dangerously wrong. This means that drug dosages, diagnostic criteria, and treatment plans were calibrated for male bodies and then applied to women without modification.
According to the European Parliament's Research Service (2025), this lack of inclusion has resulted in critical gaps in our understanding of how treatments impact women, increasing the risk of adverse drug effects and limiting treatment effectiveness. The gender health data gap impacts cancer, cardiovascular disease, Alzheimer's, and more.